can't afford glp 1 Connecticut is moving to eliminate Medicaid coverage of GLP-1 weight loss drugs like Ozempic and Mounjaro, a decision that could leave thousands of residents without access to medications that have transformed obesity The best prescription in the

The same mechanism is being deployed toward different clinical ends , and those ends influence everything from trial design to patient expectations

Blood donation organizations consistently need volunteer support beyond the donation chair, and your contribution can be equally valuable during this period

Looking to the Future Despite the estimated 20% prevalence of MCAS in the general population, there are currently no MCAS-focused clinical trials for GLP-1 receptor agonists

These changes are most pronounced in people who lose weight rapidly or who started treatment at a higher body weight

Beyond the GLP-1 patch, the company sells other patches aimed at energy, skin health, aging support, focus, and even mosquito protection